首页 | 本学科首页   官方微博 | 高级检索  
     


Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter study
Authors:María Castellanos-Gonzalez  Beatriz Butrón Bris  Isabel Bielsa Marsol  Mónica Munera Campos  Ricardo Ruiz-Villaverde  Concha Postigo Llorente  Almudena Nuno-Gonzalez  Jesús Tercedor Sánchez  Eva Chavarría Mur  Rosa Giménez García  Ana Bauza Alonso  Gloria Aparicio Español  Yolanda Hidalgo García  Júlia María Sánchez Schmidt  Manuel Almagro Sánchez  Esther Roé Crespo  Elena de Las Heras Alonso  Gonzalo Gallo-Pineda  Jose Antonio Avilés Izquierdo  David Varillas-Delgado
Affiliation:1. Dermatology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain;2. Dermatology Service, Hospital Universitario San Cecilio, Granada, Spain;3. Dermatology Service, Hospital Universitario 12 de Octubre, Madrid, Spain;4. Dermatology Service, Hospital Universitario La Paz, Madrid, Spain;5. Dermatology Service, Hospital Virgen de las Nieves, Granada, Spain;6. Dermatology Service, Hospital Infanta Leonor, Madrid, Spain;7. Dermatology Service, Hospital Universitario Río Hortega, Valladolid, Spain;8. Dermatology Service, Hospital Universitario Son Espases, Palma de Mallorca, Spain;9. Dermatology Service, Hospital Universitari Vall d´Hebron, Barcelona, Spain;10. Dermatology Service, Hospital Universitario Central de Asturias, Oviedo, Spain;11. Dermatology Service, Hospital del Mar, Barcelona, Spain;12. Dermatology Service, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain;13. Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;14. Dermatology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain;15. Dermatology Service, Hospital Universitario Puerta del Mar, Cádiz, Spain;16. Dermatology Service, Hospital General Gregorio Marañon, Madrid, Spain;17. Faculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain
Abstract:Background and objectives : Melanoma differentiation-associated gene 5 antibody (anti-MDA5) in dermatomyositis (DM) is associated with rapidly progressive interstitial lung disease and poor prognosis. Early diagnosis is key to improving the prognosis of these patients. The aim was to confirm cutaneous characteristics in patients with anti-MDA5 dermatomyositis and to explore new diagnostic markers for the presence of anti-MDA5 (anti-MDA5+). Patients and Methods : A multicenter cross-sectional retrospective cohort study of 124 patients diagnosed with DM, of which 37 were anti-MDA5+. Demographic data, laboratory data, and clinical manifestations were collected. Results : Anti-MDA5+ DM is characterized by a distinct mucocutaneous phenotype that includes oral lesions, alopecia, mechanic's hands, palmar and dorsal papules, palmar erythema, vasculopathy, and skin ulceration. We found vasculopathy and digit tip involvement very frequently in anti-MDA5+ patients (p <0.001), being a diagnostic marker of anti-MDA5+ (OR, 12.355; 95% CI 2.850–79.263; p  =  0.012 and OR, 7.447; 95% CI 2.103–46.718; p  =  0.004, respectively). The presence of ulcers deserves special mention, especially in anti-MDA5+ patients, because in our cohort, up to 97% of the anti-MDA5+ patients had ulcers. Conclusions : In patients with suspected DM with digit tip involvement or vasculopathy, the presence of anti-MDA5 antibodies must be ruled out, as it may be a clinical predictor.
Keywords:anti-MDA5  arthritis  Dermatomyositis  ulcers  vasculopathy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号